Oncology Letters-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=801897, encodeId=232a80189e3c, content=2月8号投，3月28号一审回来，两个审稿人提了十几个问题，补了实验，5月1号修回，5月7号编辑回信提了三个问题，要求提供伦理批件，患者知情同意，回复之后，5月15号发来邮件暂时接收，等Word proof，改了三次，第一次提了50几个问题，实在心累，7月3号发来pdf proof，交钱，今天终于online。以前听说是水刊，感觉并不是，非常严格，想吐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/18/6ac3fcb9de9728bbbe08b85648b25b8b.jpg, createdBy=bf772570439, createdName=浅海的的鱼, createdTime=Thu Jul 09 19:56:51 CST 2020, time=2020-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126814, encodeId=69702126814b1, content=投稿4个月了，一直under review，给编辑两次邮件，每次都回undergoing peer review。很纠结要不要撤稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=310f8460688, createdName=ms9000000086451296, createdTime=Tue Apr 18 19:11:12 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2094158, encodeId=ec00209415888, content=推荐转投过来，一直都是under review。快一个月了，没任何反应。这是在外审啊还是搁置状态啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dcb5712181, createdName=ms1000000960984308, createdTime=Mon Oct 17 09:59:31 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097624, encodeId=bf6b209e62469, content=9.13投的一篇综述，投完第二天就under review了，现在10.31了还一直是under review，请问老师们知道这是什么情况吗？是送外审了还是在编辑手里，还要继续等吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221106/5f7f95357a3d4a089ac253c47ce0eeaf/94a8b931e92e418795495b47d393083d.jpg, createdBy=8bbc8321893, createdName=ms8000001824437637, createdTime=Mon Oct 31 16:08:30 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104793, encodeId=22aa2104e930e, content=偏重的研究方向：肿瘤 经验分享：投了一篇case，7天under review，希望有好消息吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Wed Dec 07 16:35:46 CST 2022, time=2022-12-07, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1229773, encodeId=ad851229e73e0, content=2022.06.27投稿，编号286987，2022.6.30再投一文，编号287088，是不是意味着3天收到稿件量101篇？那么一年就是12288篇。2021年一共见刊921篇，921÷12288=0.075，接收率7.5%。大概可以反映这个期刊接收率在10%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Thu Jun 30 19:48:24 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916680, encodeId=f547916680d0, content=审稿速度:3.0 经验分享：一审外审70天了，还是under review, 跪了……好方……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1c5wBhZkAAOles9CicxDibAe8O6v8xD2lmSH6ePWGOFCoTOLtGa4fQ8LcbATaBEibv4b4PibXIheS2c/0, createdBy=40051950462, createdName=大王椰子, createdTime=Thu Jan 14 23:04:15 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601857, encodeId=5ff560185e1a, content=请问被接收的朋友是不是一般都找2个审稿人？外审一般多久？我这边等四个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd15116811, createdName=14628cc5m72暂无昵称, createdTime=Tue Jun 09 08:40:50 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591267, encodeId=dea159126e0a, content=不要急我历经八个月终于在刚刚被接受了祝好运159****6542暂无昵称 2020-04-11 发表:: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉159****6542暂无昵称 2020-04-11 00:00:00 发表: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉, beContent=159****6542暂无昵称 2020-04-11 发表:: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=340c5124171, createdName=14640a00m50(暂无昵称), createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958530, encodeId=cbe895853005, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 ; 细胞 经验分享：将近2个月了，催了三次，一直under review ，崩溃了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=117d5435449, createdName=ms7000000659667916, createdTime=Mon Apr 19 22:40:44 CST 2021, time=2021-04-19, status=1, ipAttribution=)]

2020-07-09 浅海的的鱼

2月8号投，3月28号一审回来，两个审稿人提了十几个问题，补了实验，5月1号修回，5月7号编辑回信提了三个问题，要求提供伦理批件，患者知情同意，回复之后，5月15号发来邮件暂时接收，等Word proof，改了三次，第一次提了50几个问题，实在心累，7月3号发来pdf proof，交钱，今天终于online。以前听说是水刊，感觉并不是，非常严格，想吐。

251 32

展开32条回复

[GetPortalCommentsPageByObjectIdResponse(id=801897, encodeId=232a80189e3c, content=2月8号投，3月28号一审回来，两个审稿人提了十几个问题，补了实验，5月1号修回，5月7号编辑回信提了三个问题，要求提供伦理批件，患者知情同意，回复之后，5月15号发来邮件暂时接收，等Word proof，改了三次，第一次提了50几个问题，实在心累，7月3号发来pdf proof，交钱，今天终于online。以前听说是水刊，感觉并不是，非常严格，想吐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/18/6ac3fcb9de9728bbbe08b85648b25b8b.jpg, createdBy=bf772570439, createdName=浅海的的鱼, createdTime=Thu Jul 09 19:56:51 CST 2020, time=2020-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126814, encodeId=69702126814b1, content=投稿4个月了，一直under review，给编辑两次邮件，每次都回undergoing peer review。很纠结要不要撤稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=310f8460688, createdName=ms9000000086451296, createdTime=Tue Apr 18 19:11:12 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2094158, encodeId=ec00209415888, content=推荐转投过来，一直都是under review。快一个月了，没任何反应。这是在外审啊还是搁置状态啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dcb5712181, createdName=ms1000000960984308, createdTime=Mon Oct 17 09:59:31 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097624, encodeId=bf6b209e62469, content=9.13投的一篇综述，投完第二天就under review了，现在10.31了还一直是under review，请问老师们知道这是什么情况吗？是送外审了还是在编辑手里，还要继续等吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221106/5f7f95357a3d4a089ac253c47ce0eeaf/94a8b931e92e418795495b47d393083d.jpg, createdBy=8bbc8321893, createdName=ms8000001824437637, createdTime=Mon Oct 31 16:08:30 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104793, encodeId=22aa2104e930e, content=偏重的研究方向：肿瘤 经验分享：投了一篇case，7天under review，希望有好消息吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Wed Dec 07 16:35:46 CST 2022, time=2022-12-07, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1229773, encodeId=ad851229e73e0, content=2022.06.27投稿，编号286987，2022.6.30再投一文，编号287088，是不是意味着3天收到稿件量101篇？那么一年就是12288篇。2021年一共见刊921篇，921÷12288=0.075，接收率7.5%。大概可以反映这个期刊接收率在10%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Thu Jun 30 19:48:24 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916680, encodeId=f547916680d0, content=审稿速度:3.0 经验分享：一审外审70天了，还是under review, 跪了……好方……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1c5wBhZkAAOles9CicxDibAe8O6v8xD2lmSH6ePWGOFCoTOLtGa4fQ8LcbATaBEibv4b4PibXIheS2c/0, createdBy=40051950462, createdName=大王椰子, createdTime=Thu Jan 14 23:04:15 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601857, encodeId=5ff560185e1a, content=请问被接收的朋友是不是一般都找2个审稿人？外审一般多久？我这边等四个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd15116811, createdName=14628cc5m72暂无昵称, createdTime=Tue Jun 09 08:40:50 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591267, encodeId=dea159126e0a, content=不要急我历经八个月终于在刚刚被接受了祝好运159****6542暂无昵称 2020-04-11 发表:: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉159****6542暂无昵称 2020-04-11 00:00:00 发表: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉, beContent=159****6542暂无昵称 2020-04-11 发表:: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=340c5124171, createdName=14640a00m50(暂无昵称), createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958530, encodeId=cbe895853005, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 ; 细胞 经验分享：将近2个月了，催了三次，一直under review ，崩溃了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=117d5435449, createdName=ms7000000659667916, createdTime=Mon Apr 19 22:40:44 CST 2021, time=2021-04-19, status=1, ipAttribution=)]

2023-04-18 ms9000000086451296 来自广东省

投稿4个月了，一直under review，给编辑两次邮件，每次都回undergoing peer review。很纠结要不要撤稿重投

51 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=801897, encodeId=232a80189e3c, content=2月8号投，3月28号一审回来，两个审稿人提了十几个问题，补了实验，5月1号修回，5月7号编辑回信提了三个问题，要求提供伦理批件，患者知情同意，回复之后，5月15号发来邮件暂时接收，等Word proof，改了三次，第一次提了50几个问题，实在心累，7月3号发来pdf proof，交钱，今天终于online。以前听说是水刊，感觉并不是，非常严格，想吐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/18/6ac3fcb9de9728bbbe08b85648b25b8b.jpg, createdBy=bf772570439, createdName=浅海的的鱼, createdTime=Thu Jul 09 19:56:51 CST 2020, time=2020-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126814, encodeId=69702126814b1, content=投稿4个月了，一直under review，给编辑两次邮件，每次都回undergoing peer review。很纠结要不要撤稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=310f8460688, createdName=ms9000000086451296, createdTime=Tue Apr 18 19:11:12 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2094158, encodeId=ec00209415888, content=推荐转投过来，一直都是under review。快一个月了，没任何反应。这是在外审啊还是搁置状态啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dcb5712181, createdName=ms1000000960984308, createdTime=Mon Oct 17 09:59:31 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097624, encodeId=bf6b209e62469, content=9.13投的一篇综述，投完第二天就under review了，现在10.31了还一直是under review，请问老师们知道这是什么情况吗？是送外审了还是在编辑手里，还要继续等吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221106/5f7f95357a3d4a089ac253c47ce0eeaf/94a8b931e92e418795495b47d393083d.jpg, createdBy=8bbc8321893, createdName=ms8000001824437637, createdTime=Mon Oct 31 16:08:30 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104793, encodeId=22aa2104e930e, content=偏重的研究方向：肿瘤 经验分享：投了一篇case，7天under review，希望有好消息吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Wed Dec 07 16:35:46 CST 2022, time=2022-12-07, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1229773, encodeId=ad851229e73e0, content=2022.06.27投稿，编号286987，2022.6.30再投一文，编号287088，是不是意味着3天收到稿件量101篇？那么一年就是12288篇。2021年一共见刊921篇，921÷12288=0.075，接收率7.5%。大概可以反映这个期刊接收率在10%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Thu Jun 30 19:48:24 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916680, encodeId=f547916680d0, content=审稿速度:3.0 经验分享：一审外审70天了，还是under review, 跪了……好方……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1c5wBhZkAAOles9CicxDibAe8O6v8xD2lmSH6ePWGOFCoTOLtGa4fQ8LcbATaBEibv4b4PibXIheS2c/0, createdBy=40051950462, createdName=大王椰子, createdTime=Thu Jan 14 23:04:15 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601857, encodeId=5ff560185e1a, content=请问被接收的朋友是不是一般都找2个审稿人？外审一般多久？我这边等四个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd15116811, createdName=14628cc5m72暂无昵称, createdTime=Tue Jun 09 08:40:50 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591267, encodeId=dea159126e0a, content=不要急我历经八个月终于在刚刚被接受了祝好运159****6542暂无昵称 2020-04-11 发表:: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉159****6542暂无昵称 2020-04-11 00:00:00 发表: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉, beContent=159****6542暂无昵称 2020-04-11 发表:: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=340c5124171, createdName=14640a00m50(暂无昵称), createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958530, encodeId=cbe895853005, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 ; 细胞 经验分享：将近2个月了，催了三次，一直under review ，崩溃了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=117d5435449, createdName=ms7000000659667916, createdTime=Mon Apr 19 22:40:44 CST 2021, time=2021-04-19, status=1, ipAttribution=)]

2022-10-17 ms1000000960984308

推荐转投过来，一直都是under review。快一个月了，没任何反应。这是在外审啊还是搁置状态啊?

56 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=801897, encodeId=232a80189e3c, content=2月8号投，3月28号一审回来，两个审稿人提了十几个问题，补了实验，5月1号修回，5月7号编辑回信提了三个问题，要求提供伦理批件，患者知情同意，回复之后，5月15号发来邮件暂时接收，等Word proof，改了三次，第一次提了50几个问题，实在心累，7月3号发来pdf proof，交钱，今天终于online。以前听说是水刊，感觉并不是，非常严格，想吐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/18/6ac3fcb9de9728bbbe08b85648b25b8b.jpg, createdBy=bf772570439, createdName=浅海的的鱼, createdTime=Thu Jul 09 19:56:51 CST 2020, time=2020-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126814, encodeId=69702126814b1, content=投稿4个月了，一直under review，给编辑两次邮件，每次都回undergoing peer review。很纠结要不要撤稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=310f8460688, createdName=ms9000000086451296, createdTime=Tue Apr 18 19:11:12 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2094158, encodeId=ec00209415888, content=推荐转投过来，一直都是under review。快一个月了，没任何反应。这是在外审啊还是搁置状态啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dcb5712181, createdName=ms1000000960984308, createdTime=Mon Oct 17 09:59:31 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097624, encodeId=bf6b209e62469, content=9.13投的一篇综述，投完第二天就under review了，现在10.31了还一直是under review，请问老师们知道这是什么情况吗？是送外审了还是在编辑手里，还要继续等吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221106/5f7f95357a3d4a089ac253c47ce0eeaf/94a8b931e92e418795495b47d393083d.jpg, createdBy=8bbc8321893, createdName=ms8000001824437637, createdTime=Mon Oct 31 16:08:30 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104793, encodeId=22aa2104e930e, content=偏重的研究方向：肿瘤 经验分享：投了一篇case，7天under review，希望有好消息吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Wed Dec 07 16:35:46 CST 2022, time=2022-12-07, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1229773, encodeId=ad851229e73e0, content=2022.06.27投稿，编号286987，2022.6.30再投一文，编号287088，是不是意味着3天收到稿件量101篇？那么一年就是12288篇。2021年一共见刊921篇，921÷12288=0.075，接收率7.5%。大概可以反映这个期刊接收率在10%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Thu Jun 30 19:48:24 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916680, encodeId=f547916680d0, content=审稿速度:3.0 经验分享：一审外审70天了，还是under review, 跪了……好方……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1c5wBhZkAAOles9CicxDibAe8O6v8xD2lmSH6ePWGOFCoTOLtGa4fQ8LcbATaBEibv4b4PibXIheS2c/0, createdBy=40051950462, createdName=大王椰子, createdTime=Thu Jan 14 23:04:15 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601857, encodeId=5ff560185e1a, content=请问被接收的朋友是不是一般都找2个审稿人？外审一般多久？我这边等四个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd15116811, createdName=14628cc5m72暂无昵称, createdTime=Tue Jun 09 08:40:50 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591267, encodeId=dea159126e0a, content=不要急我历经八个月终于在刚刚被接受了祝好运159****6542暂无昵称 2020-04-11 发表:: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉159****6542暂无昵称 2020-04-11 00:00:00 发表: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉, beContent=159****6542暂无昵称 2020-04-11 发表:: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=340c5124171, createdName=14640a00m50(暂无昵称), createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958530, encodeId=cbe895853005, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 ; 细胞 经验分享：将近2个月了，催了三次，一直under review ，崩溃了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=117d5435449, createdName=ms7000000659667916, createdTime=Mon Apr 19 22:40:44 CST 2021, time=2021-04-19, status=1, ipAttribution=)]

2022-10-31 ms8000001824437637

9.13投的一篇综述，投完第二天就under review了，现在10.31了还一直是under review，请问老师们知道这是什么情况吗？是送外审了还是在编辑手里，还要继续等吗？

145 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=801897, encodeId=232a80189e3c, content=2月8号投，3月28号一审回来，两个审稿人提了十几个问题，补了实验，5月1号修回，5月7号编辑回信提了三个问题，要求提供伦理批件，患者知情同意，回复之后，5月15号发来邮件暂时接收，等Word proof，改了三次，第一次提了50几个问题，实在心累，7月3号发来pdf proof，交钱，今天终于online。以前听说是水刊，感觉并不是，非常严格，想吐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/18/6ac3fcb9de9728bbbe08b85648b25b8b.jpg, createdBy=bf772570439, createdName=浅海的的鱼, createdTime=Thu Jul 09 19:56:51 CST 2020, time=2020-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126814, encodeId=69702126814b1, content=投稿4个月了，一直under review，给编辑两次邮件，每次都回undergoing peer review。很纠结要不要撤稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=310f8460688, createdName=ms9000000086451296, createdTime=Tue Apr 18 19:11:12 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2094158, encodeId=ec00209415888, content=推荐转投过来，一直都是under review。快一个月了，没任何反应。这是在外审啊还是搁置状态啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dcb5712181, createdName=ms1000000960984308, createdTime=Mon Oct 17 09:59:31 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097624, encodeId=bf6b209e62469, content=9.13投的一篇综述，投完第二天就under review了，现在10.31了还一直是under review，请问老师们知道这是什么情况吗？是送外审了还是在编辑手里，还要继续等吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221106/5f7f95357a3d4a089ac253c47ce0eeaf/94a8b931e92e418795495b47d393083d.jpg, createdBy=8bbc8321893, createdName=ms8000001824437637, createdTime=Mon Oct 31 16:08:30 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104793, encodeId=22aa2104e930e, content=偏重的研究方向：肿瘤 经验分享：投了一篇case，7天under review，希望有好消息吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Wed Dec 07 16:35:46 CST 2022, time=2022-12-07, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1229773, encodeId=ad851229e73e0, content=2022.06.27投稿，编号286987，2022.6.30再投一文，编号287088，是不是意味着3天收到稿件量101篇？那么一年就是12288篇。2021年一共见刊921篇，921÷12288=0.075，接收率7.5%。大概可以反映这个期刊接收率在10%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Thu Jun 30 19:48:24 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916680, encodeId=f547916680d0, content=审稿速度:3.0 经验分享：一审外审70天了，还是under review, 跪了……好方……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1c5wBhZkAAOles9CicxDibAe8O6v8xD2lmSH6ePWGOFCoTOLtGa4fQ8LcbATaBEibv4b4PibXIheS2c/0, createdBy=40051950462, createdName=大王椰子, createdTime=Thu Jan 14 23:04:15 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601857, encodeId=5ff560185e1a, content=请问被接收的朋友是不是一般都找2个审稿人？外审一般多久？我这边等四个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd15116811, createdName=14628cc5m72暂无昵称, createdTime=Tue Jun 09 08:40:50 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591267, encodeId=dea159126e0a, content=不要急我历经八个月终于在刚刚被接受了祝好运159****6542暂无昵称 2020-04-11 发表:: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉159****6542暂无昵称 2020-04-11 00:00:00 发表: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉, beContent=159****6542暂无昵称 2020-04-11 发表:: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=340c5124171, createdName=14640a00m50(暂无昵称), createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958530, encodeId=cbe895853005, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 ; 细胞 经验分享：将近2个月了，催了三次，一直under review ，崩溃了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=117d5435449, createdName=ms7000000659667916, createdTime=Mon Apr 19 22:40:44 CST 2021, time=2021-04-19, status=1, ipAttribution=)]

2022-12-07 ms5000000029332336 来自辽宁省

偏重的研究方向：肿瘤
经验分享：投了一篇case，7天under review，希望有好消息吧。

44 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=801897, encodeId=232a80189e3c, content=2月8号投，3月28号一审回来，两个审稿人提了十几个问题，补了实验，5月1号修回，5月7号编辑回信提了三个问题，要求提供伦理批件，患者知情同意，回复之后，5月15号发来邮件暂时接收，等Word proof，改了三次，第一次提了50几个问题，实在心累，7月3号发来pdf proof，交钱，今天终于online。以前听说是水刊，感觉并不是，非常严格，想吐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/18/6ac3fcb9de9728bbbe08b85648b25b8b.jpg, createdBy=bf772570439, createdName=浅海的的鱼, createdTime=Thu Jul 09 19:56:51 CST 2020, time=2020-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126814, encodeId=69702126814b1, content=投稿4个月了，一直under review，给编辑两次邮件，每次都回undergoing peer review。很纠结要不要撤稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=310f8460688, createdName=ms9000000086451296, createdTime=Tue Apr 18 19:11:12 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2094158, encodeId=ec00209415888, content=推荐转投过来，一直都是under review。快一个月了，没任何反应。这是在外审啊还是搁置状态啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dcb5712181, createdName=ms1000000960984308, createdTime=Mon Oct 17 09:59:31 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097624, encodeId=bf6b209e62469, content=9.13投的一篇综述，投完第二天就under review了，现在10.31了还一直是under review，请问老师们知道这是什么情况吗？是送外审了还是在编辑手里，还要继续等吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221106/5f7f95357a3d4a089ac253c47ce0eeaf/94a8b931e92e418795495b47d393083d.jpg, createdBy=8bbc8321893, createdName=ms8000001824437637, createdTime=Mon Oct 31 16:08:30 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104793, encodeId=22aa2104e930e, content=偏重的研究方向：肿瘤 经验分享：投了一篇case，7天under review，希望有好消息吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Wed Dec 07 16:35:46 CST 2022, time=2022-12-07, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1229773, encodeId=ad851229e73e0, content=2022.06.27投稿，编号286987，2022.6.30再投一文，编号287088，是不是意味着3天收到稿件量101篇？那么一年就是12288篇。2021年一共见刊921篇，921÷12288=0.075，接收率7.5%。大概可以反映这个期刊接收率在10%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Thu Jun 30 19:48:24 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916680, encodeId=f547916680d0, content=审稿速度:3.0 经验分享：一审外审70天了，还是under review, 跪了……好方……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1c5wBhZkAAOles9CicxDibAe8O6v8xD2lmSH6ePWGOFCoTOLtGa4fQ8LcbATaBEibv4b4PibXIheS2c/0, createdBy=40051950462, createdName=大王椰子, createdTime=Thu Jan 14 23:04:15 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601857, encodeId=5ff560185e1a, content=请问被接收的朋友是不是一般都找2个审稿人？外审一般多久？我这边等四个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd15116811, createdName=14628cc5m72暂无昵称, createdTime=Tue Jun 09 08:40:50 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591267, encodeId=dea159126e0a, content=不要急我历经八个月终于在刚刚被接受了祝好运159****6542暂无昵称 2020-04-11 发表:: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉159****6542暂无昵称 2020-04-11 00:00:00 发表: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉, beContent=159****6542暂无昵称 2020-04-11 发表:: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=340c5124171, createdName=14640a00m50(暂无昵称), createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958530, encodeId=cbe895853005, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 ; 细胞 经验分享：将近2个月了，催了三次，一直under review ，崩溃了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=117d5435449, createdName=ms7000000659667916, createdTime=Mon Apr 19 22:40:44 CST 2021, time=2021-04-19, status=1, ipAttribution=)]

2022-06-30 ms7000002110969436

2022.06.27投稿，编号286987，2022.6.30再投一文，编号287088，是不是意味着3天收到稿件量101篇？那么一年就是12288篇。2021年一共见刊921篇，921÷12288=0.075，接收率7.5%。大概可以反映这个期刊接收率在10%左右。

55 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=801897, encodeId=232a80189e3c, content=2月8号投，3月28号一审回来，两个审稿人提了十几个问题，补了实验，5月1号修回，5月7号编辑回信提了三个问题，要求提供伦理批件，患者知情同意，回复之后，5月15号发来邮件暂时接收，等Word proof，改了三次，第一次提了50几个问题，实在心累，7月3号发来pdf proof，交钱，今天终于online。以前听说是水刊，感觉并不是，非常严格，想吐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/18/6ac3fcb9de9728bbbe08b85648b25b8b.jpg, createdBy=bf772570439, createdName=浅海的的鱼, createdTime=Thu Jul 09 19:56:51 CST 2020, time=2020-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126814, encodeId=69702126814b1, content=投稿4个月了，一直under review，给编辑两次邮件，每次都回undergoing peer review。很纠结要不要撤稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=310f8460688, createdName=ms9000000086451296, createdTime=Tue Apr 18 19:11:12 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2094158, encodeId=ec00209415888, content=推荐转投过来，一直都是under review。快一个月了，没任何反应。这是在外审啊还是搁置状态啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dcb5712181, createdName=ms1000000960984308, createdTime=Mon Oct 17 09:59:31 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097624, encodeId=bf6b209e62469, content=9.13投的一篇综述，投完第二天就under review了，现在10.31了还一直是under review，请问老师们知道这是什么情况吗？是送外审了还是在编辑手里，还要继续等吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221106/5f7f95357a3d4a089ac253c47ce0eeaf/94a8b931e92e418795495b47d393083d.jpg, createdBy=8bbc8321893, createdName=ms8000001824437637, createdTime=Mon Oct 31 16:08:30 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104793, encodeId=22aa2104e930e, content=偏重的研究方向：肿瘤 经验分享：投了一篇case，7天under review，希望有好消息吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Wed Dec 07 16:35:46 CST 2022, time=2022-12-07, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1229773, encodeId=ad851229e73e0, content=2022.06.27投稿，编号286987，2022.6.30再投一文，编号287088，是不是意味着3天收到稿件量101篇？那么一年就是12288篇。2021年一共见刊921篇，921÷12288=0.075，接收率7.5%。大概可以反映这个期刊接收率在10%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Thu Jun 30 19:48:24 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916680, encodeId=f547916680d0, content=审稿速度:3.0 经验分享：一审外审70天了，还是under review, 跪了……好方……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1c5wBhZkAAOles9CicxDibAe8O6v8xD2lmSH6ePWGOFCoTOLtGa4fQ8LcbATaBEibv4b4PibXIheS2c/0, createdBy=40051950462, createdName=大王椰子, createdTime=Thu Jan 14 23:04:15 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601857, encodeId=5ff560185e1a, content=请问被接收的朋友是不是一般都找2个审稿人？外审一般多久？我这边等四个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd15116811, createdName=14628cc5m72暂无昵称, createdTime=Tue Jun 09 08:40:50 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591267, encodeId=dea159126e0a, content=不要急我历经八个月终于在刚刚被接受了祝好运159****6542暂无昵称 2020-04-11 发表:: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉159****6542暂无昵称 2020-04-11 00:00:00 发表: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉, beContent=159****6542暂无昵称 2020-04-11 发表:: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=340c5124171, createdName=14640a00m50(暂无昵称), createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958530, encodeId=cbe895853005, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 ; 细胞 经验分享：将近2个月了，催了三次，一直under review ，崩溃了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=117d5435449, createdName=ms7000000659667916, createdTime=Mon Apr 19 22:40:44 CST 2021, time=2021-04-19, status=1, ipAttribution=)]

2021-01-14 大王椰子

审稿速度:3.0
经验分享：一审外审70天了，还是under review, 跪了……好方……

128 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=801897, encodeId=232a80189e3c, content=2月8号投，3月28号一审回来，两个审稿人提了十几个问题，补了实验，5月1号修回，5月7号编辑回信提了三个问题，要求提供伦理批件，患者知情同意，回复之后，5月15号发来邮件暂时接收，等Word proof，改了三次，第一次提了50几个问题，实在心累，7月3号发来pdf proof，交钱，今天终于online。以前听说是水刊，感觉并不是，非常严格，想吐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/18/6ac3fcb9de9728bbbe08b85648b25b8b.jpg, createdBy=bf772570439, createdName=浅海的的鱼, createdTime=Thu Jul 09 19:56:51 CST 2020, time=2020-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126814, encodeId=69702126814b1, content=投稿4个月了，一直under review，给编辑两次邮件，每次都回undergoing peer review。很纠结要不要撤稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=310f8460688, createdName=ms9000000086451296, createdTime=Tue Apr 18 19:11:12 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2094158, encodeId=ec00209415888, content=推荐转投过来，一直都是under review。快一个月了，没任何反应。这是在外审啊还是搁置状态啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dcb5712181, createdName=ms1000000960984308, createdTime=Mon Oct 17 09:59:31 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097624, encodeId=bf6b209e62469, content=9.13投的一篇综述，投完第二天就under review了，现在10.31了还一直是under review，请问老师们知道这是什么情况吗？是送外审了还是在编辑手里，还要继续等吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221106/5f7f95357a3d4a089ac253c47ce0eeaf/94a8b931e92e418795495b47d393083d.jpg, createdBy=8bbc8321893, createdName=ms8000001824437637, createdTime=Mon Oct 31 16:08:30 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104793, encodeId=22aa2104e930e, content=偏重的研究方向：肿瘤 经验分享：投了一篇case，7天under review，希望有好消息吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Wed Dec 07 16:35:46 CST 2022, time=2022-12-07, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1229773, encodeId=ad851229e73e0, content=2022.06.27投稿，编号286987，2022.6.30再投一文，编号287088，是不是意味着3天收到稿件量101篇？那么一年就是12288篇。2021年一共见刊921篇，921÷12288=0.075，接收率7.5%。大概可以反映这个期刊接收率在10%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Thu Jun 30 19:48:24 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916680, encodeId=f547916680d0, content=审稿速度:3.0 经验分享：一审外审70天了，还是under review, 跪了……好方……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1c5wBhZkAAOles9CicxDibAe8O6v8xD2lmSH6ePWGOFCoTOLtGa4fQ8LcbATaBEibv4b4PibXIheS2c/0, createdBy=40051950462, createdName=大王椰子, createdTime=Thu Jan 14 23:04:15 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601857, encodeId=5ff560185e1a, content=请问被接收的朋友是不是一般都找2个审稿人？外审一般多久？我这边等四个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd15116811, createdName=14628cc5m72暂无昵称, createdTime=Tue Jun 09 08:40:50 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591267, encodeId=dea159126e0a, content=不要急我历经八个月终于在刚刚被接受了祝好运159****6542暂无昵称 2020-04-11 发表:: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉159****6542暂无昵称 2020-04-11 00:00:00 发表: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉, beContent=159****6542暂无昵称 2020-04-11 发表:: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=340c5124171, createdName=14640a00m50(暂无昵称), createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958530, encodeId=cbe895853005, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 ; 细胞 经验分享：将近2个月了，催了三次，一直under review ，崩溃了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=117d5435449, createdName=ms7000000659667916, createdTime=Mon Apr 19 22:40:44 CST 2021, time=2021-04-19, status=1, ipAttribution=)]

2020-06-09 14628cc5m72暂无昵称

请问被接收的朋友是不是一般都找2个审稿人？外审一般多久？我这边等四个月了

118 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=801897, encodeId=232a80189e3c, content=2月8号投，3月28号一审回来，两个审稿人提了十几个问题，补了实验，5月1号修回，5月7号编辑回信提了三个问题，要求提供伦理批件，患者知情同意，回复之后，5月15号发来邮件暂时接收，等Word proof，改了三次，第一次提了50几个问题，实在心累，7月3号发来pdf proof，交钱，今天终于online。以前听说是水刊，感觉并不是，非常严格，想吐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/18/6ac3fcb9de9728bbbe08b85648b25b8b.jpg, createdBy=bf772570439, createdName=浅海的的鱼, createdTime=Thu Jul 09 19:56:51 CST 2020, time=2020-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126814, encodeId=69702126814b1, content=投稿4个月了，一直under review，给编辑两次邮件，每次都回undergoing peer review。很纠结要不要撤稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=310f8460688, createdName=ms9000000086451296, createdTime=Tue Apr 18 19:11:12 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2094158, encodeId=ec00209415888, content=推荐转投过来，一直都是under review。快一个月了，没任何反应。这是在外审啊还是搁置状态啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dcb5712181, createdName=ms1000000960984308, createdTime=Mon Oct 17 09:59:31 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097624, encodeId=bf6b209e62469, content=9.13投的一篇综述，投完第二天就under review了，现在10.31了还一直是under review，请问老师们知道这是什么情况吗？是送外审了还是在编辑手里，还要继续等吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221106/5f7f95357a3d4a089ac253c47ce0eeaf/94a8b931e92e418795495b47d393083d.jpg, createdBy=8bbc8321893, createdName=ms8000001824437637, createdTime=Mon Oct 31 16:08:30 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104793, encodeId=22aa2104e930e, content=偏重的研究方向：肿瘤 经验分享：投了一篇case，7天under review，希望有好消息吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Wed Dec 07 16:35:46 CST 2022, time=2022-12-07, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1229773, encodeId=ad851229e73e0, content=2022.06.27投稿，编号286987，2022.6.30再投一文，编号287088，是不是意味着3天收到稿件量101篇？那么一年就是12288篇。2021年一共见刊921篇，921÷12288=0.075，接收率7.5%。大概可以反映这个期刊接收率在10%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Thu Jun 30 19:48:24 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916680, encodeId=f547916680d0, content=审稿速度:3.0 经验分享：一审外审70天了，还是under review, 跪了……好方……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1c5wBhZkAAOles9CicxDibAe8O6v8xD2lmSH6ePWGOFCoTOLtGa4fQ8LcbATaBEibv4b4PibXIheS2c/0, createdBy=40051950462, createdName=大王椰子, createdTime=Thu Jan 14 23:04:15 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601857, encodeId=5ff560185e1a, content=请问被接收的朋友是不是一般都找2个审稿人？外审一般多久？我这边等四个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd15116811, createdName=14628cc5m72暂无昵称, createdTime=Tue Jun 09 08:40:50 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591267, encodeId=dea159126e0a, content=不要急我历经八个月终于在刚刚被接受了祝好运159****6542暂无昵称 2020-04-11 发表:: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉159****6542暂无昵称 2020-04-11 00:00:00 发表: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉, beContent=159****6542暂无昵称 2020-04-11 发表:: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=340c5124171, createdName=14640a00m50(暂无昵称), createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958530, encodeId=cbe895853005, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 ; 细胞 经验分享：将近2个月了，催了三次，一直under review ，崩溃了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=117d5435449, createdName=ms7000000659667916, createdTime=Mon Apr 19 22:40:44 CST 2021, time=2021-04-19, status=1, ipAttribution=)]

2020-05-20 14640a00m50(暂无昵称)

不要急我历经八个月终于在刚刚被接受了祝好运159****6542暂无昵称 2020-04-11 发表::
好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉159****6542暂无昵称 2020-04-11 00:00:00 发表:
好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉

159****6542暂无昵称 2020-04-11 发表:: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉

131 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=801897, encodeId=232a80189e3c, content=2月8号投，3月28号一审回来，两个审稿人提了十几个问题，补了实验，5月1号修回，5月7号编辑回信提了三个问题，要求提供伦理批件，患者知情同意，回复之后，5月15号发来邮件暂时接收，等Word proof，改了三次，第一次提了50几个问题，实在心累，7月3号发来pdf proof，交钱，今天终于online。以前听说是水刊，感觉并不是，非常严格，想吐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/18/6ac3fcb9de9728bbbe08b85648b25b8b.jpg, createdBy=bf772570439, createdName=浅海的的鱼, createdTime=Thu Jul 09 19:56:51 CST 2020, time=2020-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126814, encodeId=69702126814b1, content=投稿4个月了，一直under review，给编辑两次邮件，每次都回undergoing peer review。很纠结要不要撤稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=310f8460688, createdName=ms9000000086451296, createdTime=Tue Apr 18 19:11:12 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2094158, encodeId=ec00209415888, content=推荐转投过来，一直都是under review。快一个月了，没任何反应。这是在外审啊还是搁置状态啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dcb5712181, createdName=ms1000000960984308, createdTime=Mon Oct 17 09:59:31 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097624, encodeId=bf6b209e62469, content=9.13投的一篇综述，投完第二天就under review了，现在10.31了还一直是under review，请问老师们知道这是什么情况吗？是送外审了还是在编辑手里，还要继续等吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221106/5f7f95357a3d4a089ac253c47ce0eeaf/94a8b931e92e418795495b47d393083d.jpg, createdBy=8bbc8321893, createdName=ms8000001824437637, createdTime=Mon Oct 31 16:08:30 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104793, encodeId=22aa2104e930e, content=偏重的研究方向：肿瘤 经验分享：投了一篇case，7天under review，希望有好消息吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Wed Dec 07 16:35:46 CST 2022, time=2022-12-07, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1229773, encodeId=ad851229e73e0, content=2022.06.27投稿，编号286987，2022.6.30再投一文，编号287088，是不是意味着3天收到稿件量101篇？那么一年就是12288篇。2021年一共见刊921篇，921÷12288=0.075，接收率7.5%。大概可以反映这个期刊接收率在10%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Thu Jun 30 19:48:24 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916680, encodeId=f547916680d0, content=审稿速度:3.0 经验分享：一审外审70天了，还是under review, 跪了……好方……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1c5wBhZkAAOles9CicxDibAe8O6v8xD2lmSH6ePWGOFCoTOLtGa4fQ8LcbATaBEibv4b4PibXIheS2c/0, createdBy=40051950462, createdName=大王椰子, createdTime=Thu Jan 14 23:04:15 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601857, encodeId=5ff560185e1a, content=请问被接收的朋友是不是一般都找2个审稿人？外审一般多久？我这边等四个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd15116811, createdName=14628cc5m72暂无昵称, createdTime=Tue Jun 09 08:40:50 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591267, encodeId=dea159126e0a, content=不要急我历经八个月终于在刚刚被接受了祝好运159****6542暂无昵称 2020-04-11 发表:: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉159****6542暂无昵称 2020-04-11 00:00:00 发表: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉, beContent=159****6542暂无昵称 2020-04-11 发表:: 好棒，羡慕啊，我这前天第三次给编辑提交了回信，今天第三天还没有消息给我，唉, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=340c5124171, createdName=14640a00m50(暂无昵称), createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958530, encodeId=cbe895853005, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 ; 细胞 经验分享：将近2个月了，催了三次，一直under review ，崩溃了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=117d5435449, createdName=ms7000000659667916, createdTime=Mon Apr 19 22:40:44 CST 2021, time=2021-04-19, status=1, ipAttribution=)]

2021-04-19 ms7000000659667916

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤 ; 细胞
经验分享：将近2个月了，催了三次，一直under review ，崩溃了

76 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务